ArticleActa pharmaceutica Sinica. B2025

New leap of BRD9 inhibitor: Imidazole substituents making BRD9 inhibitors excellent drug candidates for AML.

Edward ZhouPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.